Kategorien: China Desk, Immaterialgüterrecht, Life Sciences, Pharma, Biotechnologie, Publikationen & Präsentationen
Teilen:
30. Juni 2021 
Speaker: Dr. Stefan Kohler
Organiser: Swiss China Summit
Location: Rüschlikon
At the Swiss China Summit 2021, Stefan Kohler, Partner at VISCHER AG, moderated the panel with Dr. William Pao, Head of Pharmaceutical Research & Early Development at Roche, Bin Sheng, Partner at Succeed Consulting GmbH, and René Wiedemann, Managing Director at Accenture Switzerland, on the latest developments in the Chinese R&D environment. The panel explored the drivers of Chinese innovation and discussed the risks and opportunities facing innovative Western companies in China.